Home
Live Updates
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD - Algernon Pharmaceuticals (OTC:AGNPF) : comparemela.com
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD - Algernon Pharmaceuticals (OTC:AGNPF)
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE:AGN) (FRANKFURT: AGW0) (OTCQB:AGNPF) a Canadian clinical stage pharmaceutical development
Related Keywords
United States ,
Canada ,
Japan ,
China ,
United Kingdom ,
Vancouver ,
British Columbia ,
Canadian ,
British ,
Chinese ,
Christopherj Moreau ,
,
Algernon Pharmaceuticals ,
Company Or Algernon ,
Chinese Patent Office ,
Algernon Pharmaceuticals Inc ,
Algernon Neuroscience ,
comparemela.com © 2020. All Rights Reserved.